IL79110A0 - Polycyclic quinoline,naphthyridine and pyrazinopyridine derivatives - Google Patents

Polycyclic quinoline,naphthyridine and pyrazinopyridine derivatives

Info

Publication number
IL79110A0
IL79110A0 IL79110A IL7911086A IL79110A0 IL 79110 A0 IL79110 A0 IL 79110A0 IL 79110 A IL79110 A IL 79110A IL 7911086 A IL7911086 A IL 7911086A IL 79110 A0 IL79110 A0 IL 79110A0
Authority
IL
Israel
Prior art keywords
naphthyridine
polycyclic
pyrazinopyridine
derivatives
polycyclic quinoline
Prior art date
Application number
IL79110A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL79110A0 publication Critical patent/IL79110A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Quinoline Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
IL79110A 1985-06-13 1986-06-12 Polycyclic quinoline,naphthyridine and pyrazinopyridine derivatives IL79110A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74486585A 1985-06-13 1985-06-13
US86178886A 1986-05-15 1986-05-15

Publications (1)

Publication Number Publication Date
IL79110A0 true IL79110A0 (en) 1986-09-30

Family

ID=27114362

Family Applications (1)

Application Number Title Priority Date Filing Date
IL79110A IL79110A0 (en) 1985-06-13 1986-06-12 Polycyclic quinoline,naphthyridine and pyrazinopyridine derivatives

Country Status (19)

Country Link
EP (1) EP0229823B1 (ja)
JP (1) JPH0762017B2 (ja)
KR (1) KR900004831B1 (ja)
AT (1) ATE67764T1 (ja)
AU (1) AU591922B2 (ja)
CA (1) CA1306255C (ja)
DE (1) DE3681719D1 (ja)
DK (1) DK70687A (ja)
GR (1) GR861530B (ja)
HK (1) HK94694A (ja)
HU (1) HU203098B (ja)
IE (1) IE60420B1 (ja)
IL (1) IL79110A0 (ja)
MY (1) MY101808A (ja)
NO (1) NO168177C (ja)
NZ (1) NZ216519A (ja)
OA (1) OA08480A (ja)
PT (1) PT82752B (ja)
WO (1) WO1986007359A2 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3609795A1 (de) * 1986-03-22 1987-09-24 Goedecke Ag Pyrido(4,3-b)(1,6)naphthyridin-derivate, verfahren zu deren herstellung und deren verwendung
US5366971A (en) * 1987-11-09 1994-11-22 Sandoz Ltd. Use of 11,28-dioxa-4-azatricyclo[22.3.1.04,9 ]octacos-18-ene derivatives and pharmaceutical compositions containing them
JPH10501932A (ja) * 1994-04-08 1998-02-17 プレビュー インターナショナル， インコーポレイテッド インタラクティブスクロールプログラムガイド
BR9508037A (pt) * 1994-06-14 1997-09-16 Dainippon Pharmaceutical Co Derivados de piridona-ácido carboxilico agente anti-tumor composição farmacológica e processo para preparar derivados de piridona-ácido carboxilico
US6541470B1 (en) * 1999-08-30 2003-04-01 Maruishi Pharmaceutical Co., Ltd. 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds
US9625475B2 (en) 2008-09-29 2017-04-18 Abbvie Inc. Indole and indoline derivatives and methods of use thereof
HU231285B1 (hu) 2018-04-18 2022-08-28 Printnet Kereskedelmi És Szolgáltató Kft. A miozin-2-izoformákat szelektíven gátló, gyógyászatilag hatásos vegyületek

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1585099A (ja) * 1967-07-13 1970-01-09
DE2803541A1 (de) * 1978-01-27 1979-08-02 Sandoz Ag Neue chinolinderivate, ihre herstellung und verwendung
US4680298A (en) * 1983-05-31 1987-07-14 Schering Corporation Tricyclic anti-allergy and use as anti-inflammatory agents

Also Published As

Publication number Publication date
AU591922B2 (en) 1989-12-21
PT82752A (en) 1986-07-01
WO1986007359A2 (en) 1986-12-18
NO168177C (no) 1992-01-22
MY101808A (en) 1992-01-31
KR870700622A (ko) 1987-12-30
EP0229823A1 (en) 1987-07-29
HU203098B (en) 1991-05-28
HK94694A (en) 1994-09-16
OA08480A (en) 1988-07-29
ATE67764T1 (de) 1991-10-15
GR861530B (en) 1986-12-31
KR900004831B1 (ko) 1990-07-07
EP0229823B1 (en) 1991-09-25
NZ216519A (en) 1989-02-24
DE3681719D1 (de) 1991-10-31
IE861565L (en) 1986-12-13
NO168177B (no) 1991-10-14
DK70687D0 (da) 1987-02-12
IE60420B1 (en) 1994-07-13
NO870564L (no) 1987-02-12
DK70687A (da) 1987-02-12
AU6122486A (en) 1987-01-07
NO870564D0 (no) 1987-02-12
CA1306255C (en) 1992-08-11
JPS63500518A (ja) 1988-02-25
WO1986007359A3 (en) 1987-04-09
HUT42482A (en) 1987-07-28
PT82752B (pt) 1988-12-15
JPH0762017B2 (ja) 1995-07-05

Similar Documents

Publication Publication Date Title
NO875378L (no) Fremgangsmaate for fremstilling av granulocyttstimulerendefaktor (polypeptidderivater).
IE830934L (en) 1,8-diaza-and 1,5,8-triazanaphthalene derivatives
AU588958B2 (en) Opthlamic use of quinoline and naphthyridine antibiotics
FI882909A7 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten furanyylimetyylisubstituoitujen bentsimidatsoli- ja imidatsopyridiinijohdannaisten valmistamiseksi
IL79110A0 (en) Polycyclic quinoline,naphthyridine and pyrazinopyridine derivatives
AU2659088A (en) Method for the treatment of anxiety
NO871507L (no) Fremgangsmaate for fremstilling av arylsubstituerte nafthyridin- og pyridopyrazinderivater.
ZA814902B (en) Novel thiazol-2-yl-oxamic acid derivatives,their preparation and therapeutic agents containing these compounds
MY100071A (en) Aryl-substituted naphthyridine and pyridopyrazine derivatives
AU597249C (en) Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
AU5639886A (en) Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
JO1061B1 (en) Derivatives 4 - Amino - 3 - Carboxy or Cyano - 1, 2 - Diphenyl - 2 - Oxy - 1, 8- Naphtheridine.
IT9019066A1 (it) Formulazione combinata di cimetidina-pirenzepina per il trattamento di ulcere ed erosioni peptiche

Legal Events

Date Code Title Description
RH Patent void